Barclays Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price

Phibro Animal Health (NASDAQ:PAHC) had its target price hoisted by Barclays from $20.00 to $22.00 in a research note issued to investors on Monday,Benzinga reports. Barclays currently has an underweight rating on the stock.

A number of other brokerages also recently issued reports on PAHC. Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $26.22 on Monday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.69. The stock has a market capitalization of $1.06 billion, a price-to-earnings ratio of 54.63, a PEG ratio of 0.53 and a beta of 0.52. The firm’s 50 day simple moving average is $21.90 and its 200-day simple moving average is $21.70. Phibro Animal Health has a 12 month low of $11.24 and a 12 month high of $26.42.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Analysts expect that Phibro Animal Health will post 1.94 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Rhumbline Advisers lifted its stake in Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after acquiring an additional 484 shares during the last quarter. Los Angeles Capital Management LLC raised its holdings in shares of Phibro Animal Health by 2.1% in the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after purchasing an additional 503 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the last quarter. New York State Teachers Retirement System grew its stake in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after buying an additional 906 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.